Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT00517101
NCT00517101UnknownNot Applicable

Presence of IBD Specific Antibodies (ASCA, ALCA, ACCA, AMCA) in the Sera of Patients With Spondyloarthropathy

Tel-Aviv Sourasky Medical Center0 sitesStarted: September 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Study OverviewStudy DesignEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

A relationship between IBD and spondyloarthropathy is well recognized. ASCA ( anti saccharomyces cerevisiae antibodies)are considered to be a serological marker for Crohn's disease and have been studied in patients with spondyloarthropathy with conflicting results. More recently, new serological markers for IBD have been described. These markers are antibodies to certain defined glycans , and their use may permit an improved diagnosis of IBD.

The aim of our study is to investigate wether these new serological markers are present in the sera of patients with spondyloarthropathy.

Study Design

Study Type
Observational
Observational Model
Defined Population
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •diagnosis of psoriatic arthritis, ankylosing spondylitis, or undifferentiated spondyloarthropathy

Exclusion Criteria

  • •diagnosed inflammatory bowel disease

Investigators

Sponsor Class
Other Gov

Similar Trials

Unknown
Not Applicable
Rheumatological Manifestations in Inflammatory Bowel DiseasesInflammatory Bowel Diseases
NCT03486652Assiut University70
Recruiting
Not Applicable
axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial SpondyloarthritisAxial SpondyloarthritisInflammationDysbiosisArthritisSpondylitisAxSpASpAAnkylosing SpondylitisSpondylarthritis
NCT06460805NHS Greater Glasgow and Clyde62
Recruiting
Not Applicable
Analysis of Intestinal Microbiota as a Predictor of Response to Treatment of Spondyloarthritis With BiotherapySpondyloarthritis
NCT04899154Hôpital Européen Marseille80
Not yet recruiting
Not Applicable
Prevelance of Axial Spondylosis Arthritis in Inflammatory Bowel Disease and Its RESPONSE to Tumour Necrosis Factor (TNF) Inhibitors Treatment in Assiut University HospitalInflammatory Bowel Disease (IBD)SpondylarthropathiesTNF-alpha Inhibitors
NCT06601595Mohamed Nasr100
Completed
Not Applicable
A study to investigate how common a diagnosis of axial spondyloarthritis (axSpA) is in patients with known inflammatory bowel disease (IBD) such as Crohn’s Disease and Ulcerative Colitis, and the development of a tool to direct referral of patients with suspected axSpA in IBD patients to a rheumatology specialist.
ISRCTN30265575orfolk and Norwich University Hospitals NHS Foundation Trust470